Table 4 Incidences of acute GVHD and CMV/EBV infections after ATG-conditioned haploHSCT
| Â | ATG-6 | ATG-10 | p value |
|---|---|---|---|
Acute GVHD, n (%) | |||
 Total | 21 (72.4) | 14 (45.2) | 0.03 |
 Grade II–IV | 11 (37.9) | 8 (25.8) | 0.32 |
 Grade III–IV | 4 (13.8) | 2 (6.5) | 0.35 |
Median day of onset grade II-IV aGVHD (range) | 29 (10–42) | 30 (9–80) | 0.32 |
CMV reactivation, n (%) | 22 (75.9) | 24 (77.4) | 0.89 |
Median day of onset CMV reactivation (range) | 36 (22–77) | 37.5 (22–102) | 0.73 |
EBV reactivation, n (%) | 2 (6.9) | 10 (32.2) | 0.02 |
Median day of onset EBV reactivation (range) | 60.5 (47–74) | 51 (22–102) | 0.61 |